| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02074007 Details | 2017-01-24 Interventional | 3 | 178 | Benzocaine Otitis Otitis Media Acute Otitis Me… | primary outcome measure not met - | |||
| NCT01718808 Details | 2017-01-24 Interventional | 2 | 24 | Capecitabine Cetuximab Colorectal Neop… Metastatic Colo… | FU for 3 years from randomization as initially planned is stopped as we do not expect any
changes to the endpoints in the future after one year of FU. - | |||
| NCT00927290 2008-006225-14 Details | 2017-01-24 Interventional | 3 | 40 | Pioglitazone Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… Hepatitis, Chro… Insulin Resista… Chronic Hepatit… | Suspension of use of medicine containing Pioglitazone by French regulatory agency - | |||
| NCT00571285 Details | 2017-01-24 Interventional | 4 | 31 | Cholecalciferol Ergocalciferols Vitamin D Vitamins Parkinson Disea… Parkinson's Dis… | - - | |||
| NCT00304317 Details | 2017-01-24 Interventional | 4 | 0 | Celecoxib Calculi Renal Colic Ureteral Calcul… Ureterolithiasi… | PI is no longer at the University of Minnesota - | |||
| NCT02527213 Details | 2017-01-23 Interventional | 3 | 40 | Sodium thiosulf… Calciphylaxis Calcific Uremic… | Company decision - | |||
| NCT01474122 Details | 2017-01-23 Interventional | 3 | [1 Refs] | 265 | Macitentan Scleroderma, Di… Scleroderma, Sy… Sclerosis Skin Ulcer Ulcer Digital Ulcers | company decision - | ||
| NCT00462228 Details | 2017-01-23 Interventional | 4 | 11 | Memantine Brain Injuries Brain Injuries,… Wounds and Inju… Traumatic Brain… | The study was stopped due to a lack of additional subjects. The enrollment goal for the study was 20 subjects. The study included 11 subjects but was terminated due to a lack of additional subjects. | |||
| NCT02586610 Details | 2017-01-20 Interventional | 2 | 0 | Capecitabine Pembrolizumab Rectal Neoplasm… Rectal Cancer Rectal Neoplasm | Dr. Rahma decided to run the study through a different group - | |||
| NCT00694408 Details | 2017-01-20 Interventional | 3 | 15 | Hydrocortisone Hydrocortisone … Hydrocortisone … Hydrocortisone … Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Evidence of Liv… | Study terminated due to withdrawal from market of Daclizumab - | |||
| NCT00680485 Details | 2017-01-20 Interventional | 1 | - | Ketoconazole Bacterial Infec… Communicable Di… Infections Bacterial Infec… Infections, Bac… | - - | |||
| NCT02390440 Details | 2017-01-19 Interventional | 4 | 0 | Bupivacaine Rib Fractures Pain | Did not obtain an IND. - | |||
| NCT01930890 2013-000594-69 Details | 2017-01-18 Interventional | 2 | 87 | Mycophenolic Ac… Lupus Nephritis Nephritis | Results from pre-specified criteria in study NCT01499355 (211LE201) did not demonstrate
sufficient efficacy to warrant continuation of the study Study was terminated based on the pre-specified, blinded futility analysis of Study 211LE201 (NCT01499355), which did not demonstrate sufficient efficacy to warrant continuation of the studies. Study was not terminated based on safety considerations. | |||
| NCT01499355 2011-002159-32 Details | 2017-01-18 Interventional | 2 | 276 | Mycophenolic Ac… Lupus Nephritis Nephritis | Results from pre-specified criteria did not demonstrate sufficient efficacy to warrant
continuation of the study. Study was terminated based on the review of results following the prespecified, blinded futility analysis, which did not demonstrate sufficient efficacy to warrant continuation of the study. Study was not terminated based on safety considerations. | |||
| NCT00123903 Details | 2017-01-18 Interventional | 3 | - | Carvedilol Lisinopril Metoprolol Heart Failure Hypertension Heart Failure, … | - - | |||
| NCT02129062 Details | 2017-01-16 Interventional | 2 | 3 | Ibrutinib Leukemia Leukemia, Lymph… Precursor Cell … Adult B Acute L… Adult B Acute L… Recurrent Adult… | Slow accrual. - | |||
| NCT01695330 Details | 2017-01-16 Interventional | 2 | 5 | Bortezomib Multiple Myelom… Neoplasms, Plas… | Terminated by Sponsor of this study. - | |||
| NCT01446250 Details | 2017-01-16 Interventional | 3 | 8 | Peginterferon a… Ribavirin Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… Hepatitis, Chro… | - Due to the early termination of study enrollment and discontinuation of alisporivir treatment, Amendment 1 changed the number of study arms to 2, combining Arms A and B, and none of the planned outcome measures could be evaluated. | |||
| NCT00438139 Details | 2017-01-16 Interventional | 1 | - | Dronabinol Marijuana Abuse Marijuana Depen… | - - | |||
| NCT00000577 Details | 2017-01-16 Interventional | 3 | 0 | Adrenergic Agen… Adrenergic beta… Albuterol Colchicine Hormones Asthma Lung Diseases | Record is an ACRN grant summary & not reflective of an individual trial. All ACTs conducted by
ACRN were individually registered on the PRS. - |